Literature DB >> 12763680

Antigen dependent and independent mechanisms that sustain serum antibody levels.

Elisabetta Traggiai1, Roberto Puzone, Antonio Lanzavecchia.   

Abstract

In this article, we review three mechanisms that contribute to sustaining serum antibody levels: (i) long-lived plasma cells; (ii) persisting or cross-reactive antigen, and (iii) polyclonal activation of all memory B cells. We also present a quantitative analysis of the secondary immune response that reveals the relative contribution of antigen induced short- and long-lived plasma cells versus polyclonal activation of all memory B cells. Antigenic boost sustains high levels of serum antibodies only for a few months, while polyclonal activation sustains low levels of protective antibodies for a human lifetime.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763680     DOI: 10.1016/s0264-410x(03)00198-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

Review 1.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Virology       Date:  2011-01-08       Impact factor: 3.616

2.  Maintenance of the plasma cell pool is independent of memory B cells.

Authors:  Anupama Ahuja; Shannon M Anderson; Ashraf Khalil; Mark J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

Review 3.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

4.  Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years.

Authors:  Tino F Schwarz; Marek Spaczynski; Achim Schneider; Jacek Wysocki; Andrzej Galaj; Karin Schulze; Sylviane M Poncelet; Gregory Catteau; Florence Thomas; Dominique Descamps
Journal:  Hum Vaccin       Date:  2011-09-01

Review 5.  Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.

Authors:  Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2017-08-01       Impact factor: 5.422

Review 6.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

7.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

8.  Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Authors:  Andrew J Pollard; Kirsten P Perrett; Peter C Beverley
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

9.  Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans.

Authors:  Geraldine Blanchard-Rohner; Anoop S Pulickal; Cornelia M Jol-van der Zijde; Matthew D Snape; Andrew J Pollard
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

10.  Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals.

Authors:  Micah J Benson; Raul Elgueta; William Schpero; Michael Molloy; Weijun Zhang; Edward Usherwood; Randolph J Noelle
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.